Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SBC Medical Group Holdings (SBCWW) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to 13.94%.

  • SBC Medical Group Holdings' EBITDA Margin fell 305600.0% to 13.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.67%, marking a year-over-year decrease of 74500.0%. This contributed to the annual value of 14.67% for FY2024, which is 9000.0% up from last year.
  • As of Q3 2025, SBC Medical Group Holdings' EBITDA Margin stood at 13.94%, which was down 305600.0% from 25.52% recorded in Q2 2025.
  • Over the past 5 years, SBC Medical Group Holdings' EBITDA Margin peaked at 66.21% during Q1 2025, and registered a low of 26.01% during Q4 2024.
  • Over the past 3 years, SBC Medical Group Holdings' median EBITDA Margin value was 17.91% (recorded in 2024), while the average stood at 22.99%.
  • Per our database at Business Quant, SBC Medical Group Holdings' EBITDA Margin crashed by -597200bps in 2024 and then surged by 504300bps in 2025.
  • SBC Medical Group Holdings' EBITDA Margin (Quarter) stood at 33.71% in 2023, then plummeted by -177bps to 26.01% in 2024, then skyrocketed by 154bps to 13.94% in 2025.
  • Its last three reported values are 13.94% in Q3 2025, 25.52% for Q2 2025, and 66.21% during Q1 2025.